Minimizing the Risk of Misprescribing GLP-1 RA Medications in a Digital Weight-Loss Service: Preliminary Retrospective Study (Preprint)

Abstract

UNSTRUCTURED A 6-month preliminary retrospective analysis of Australia's largest digital weight-loss service found that the company's clinicians commit prescribing errors in 2.2% of GLP-1 RA orders to weight-loss patients.